Labcorp Oncology Engager

Labcorp Oncology Engager | In-Person Event

Wednesday November 16, 2022 | Boston, MA | 7.00 ET - 9.00 ET


Please Note: This event is taking place in-person only, and online attendance will not be available.

Driving Comprehensive Precision Oncology

The Unique Role of Liquid Biopsies in Expanding Critical Biomarker Insights

It's estimated that 40-50% of cancer patients have tumors containing known clinically actionable mutations. Yet, without accessible biomarker testing, there is a risk that new biomarker-driven drugs will not reach patients who could benefit from them.

This exclusive Labcorp Oncology Engager will be focusing on the benefits of utilizing liquid biopsy alone or in conjunction with tissue-based genomic testing to empower clinical trial optimization and, ultimately, access to better treatment options for patients through precision medicine.

Bringing together Scientists, Directors, and Heads working in the LBx space of the most innovative oncology-focused biopharma and research institutions, this is the must-attend meeting to discover how to maximize patient access to these treatments and overcome the ever-increasing need to identify patients most likely to benefit from therapy.

With an insightful panel discussion among key opinion leaders followed by complimentary appetizers and drinks, this is an unmissable date for LBx leaders!

Expert Speakers:


No day selected


This Labcorp Oncology Engager Event will be held at:

Meeting Room: Commonwealth AB

Wyndham Boston Beacon Hill

5 Blossom Street

Boston, MA 02114

About Labcorp Oncology:


Labcorp Oncology is committed to advancing cancer care by pioneering scientific breakthroughs, powering better decisions through actionable data-driven patient insights and bringing healthcare within reach for all cancer patients throughout their continuum of care. With our comprehensive, specialized diagnostic services and our drug development capabilities, Labcorp is uniquely positioned to support you, from discovery through post-marketing and commercialization-using a biomarker-driven strategy throughout the entire process.

Learn more at: